1832 Asset Management
BHVN

1832 Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

1832 Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-61,700
Closed -$8.99M – 919
2022
Q2 		$8.99M Buy
+61,700
New +$8.99M 0.02% 354